Volume : 09, Issue : 09, September – 2022

Title:

13.PREVALENCE OF IRRITABLE BOWEL SYNDROME IN SAUDI ARABIA, A SYSTEMATIC REVIEW
‬

Authors :

Nadira Al-baghli , Ebtihal mohammed aleisa , Sabha Hussain Almoallem , Ezdehar Hassan Muhanna , Abeer AbdulAziz Alkhawajah , Hawra shokri alherz

Abstract :

Background: There are several Saudi Arabian reports on the diagnosis of IBS in diverse population situations. The study found that incidence rates varied across the country and that multiple etiological factors could be involved.
Objectives: The study aims to summarize current evidences on prevalence, risk factors and management approaches of irritable bowel syndrome in Saudi Arabia.
Methods: For article selection, the PubMed database and EBSCO Information Services were used. All relevant articles relevant with our topic and other articles were used in our review. Other articles that were not related to this field were excluded. The data was extracted in a specific format that was reviewed by the group members.
Conclusion: IBS prevalence rates in Saudi Arabia ranged between 7.9% in Riyadh and highest 40.7% in Qassim. Factors were significantly associated with IBS as female gender, age, phsycological status, family history, smoking, socioeconomic status as well as other factors. IBS-M was the most common sub-type in Saudi Arabia.

Cite This Article:

Please cite this article in press Nadira Al-baghli et al, Prevalence Of Irritable Bowel Syndrome In Saudi Arabia, A Systematic Review., Indo Am. J. P. Sci, 2022; 09(9).

Number of Downloads : 10

References:

1. Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology 2016. February 18 [Epub ahead of print] 10.1053/j.gastro.2016.02.031
2. Alosaimia M, Ali A, Razzak HA. Epidemiology of Irritable bowel syndrome: A systematic review of literature. J Health Inform Dev Ctries. 2016;10 Retrieved from https://www.jhidc.org/index.php/jhidc/article/view/150
3. Lovell, Rebecca M, and Alexander C Ford. “Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.” Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. 10,7 (2012): 712-721.e4. doi:10.1016/j.cgh.2012.02.029
4. Lee YJ, Park KS. Irritable bowel syndrome: Emerging paradigm in pathophysiology. World Journal of Gastroenterology. 2014;20:2456–2469. doi: 10.3748/wjg.v20.i10.2456.
5. Buono, Jessica L et al. “Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.” Health and quality of life outcomes vol. 15,1 35. 14 Feb. 2017, doi:10.1186/s12955-017-0611-2
6. Masuy, Imke et al. “Irritable bowel syndrome: diagnosis and management.” Minerva gastroenterologica e dietologica vol. 66,2 (2020): 136-150. doi:10.23736/S1121-421X.19.02640-0
7. Weaver, Kristen Ronn et al. “Irritable Bowel Syndrome.” The American journal of nursing vol. 117,6 (2017): 48-55. doi:10.1097/01.NAJ.0000520253.57459.01
8. Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clinical Epidemiology. 2014;6:71–80. doi: 10.2147/CLEP.S40245.
9. Jarrett ME, Cain KC, Burr RL, Hertig VL, Rosen SN, Heitkemper MM. Comprehensive self-management for irritable bowel syndrome: Randomized trial of in-person vs. combined in-person and telephone sessions. American Journal of Gastroenterology. 2009;104:3004–3014. doi: 10.1038/ajg.2009.479.
10. Mullin GE, Shepherd SJ, Chander Roland B, Ireton-Jones C, Matarese LE. Irritable bowel syndrome: Contemporary nutrition management strategies. Journal of Parenteral and Enteral Nutrition. 2014;38:781–799. doi: 10.1177/0148607114545329.
11. Tong A, et al. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012;12(1):181.
12. Amin, Hussein S et al. “The prevalence of irritable bowel syndrome among Saudi population in Riyadh by use of Rome IV criteria and self-reported dietary restriction.” Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association vol. 27,6 (2021): 383-390. doi:10.4103/sjg.sjg_43_21
13. Arishi, Abdulelah M et al. “Irritable Bowel Syndrome: Prevalence and Risk Factors in Jazan Region, Saudi Arabia.” Cureus vol. 13,6 e15979. 28 Jun. 2021, doi:10.7759/cureus.15979
14. Alqahtani, Naif H, and Mohammad Eid M Mahfouz. “The Prevalence and Risk Factors of Irritable Bowel Syndrome in Saudi Arabia in 2019.” International journal of preventive medicine vol. 13 13. 19 Jan. 2022, doi:10.4103/ijpvm.IJPVM_486_20
15. AlAmeel, Turki et al. “The Prevalence of Irritable Bowel Syndrome Among Board-Certified Medical Doctors In Saudi Arabia: A Cross-sectional Study.” Journal of the Canadian Association of Gastroenterology vol. 3,6 e32-e36. 11 Jun. 2019, doi:10.1093/jcag/gwz020
16. Alharbi, Wjdan, and Saulat Jahan. “Prevalence and Associated Risk Factors of Irritable Bowel Syndrome Among Female Secondary School students in Ar Rass City, Qassim Region.” Health psychology research vol. 10,3 35482. 30 May. 2022, doi:10.52965/001c.35482
17. Aljammaz, K I et al. “Irritable bowel syndrome: Epidemiology and risk factors in the adult Saudi population of the central region.” Nigerian journal of clinical practice vol. 23,10 (2020): 1414-1418. doi:10.4103/njcp.njcp_382_19
18. AlKhalifah, Muhannad I et al. “Prevalence of irritable bowel syndrome among Qassim school teachers, and its impact on their performance and life duties.” Saudi medical journal vol. 37,7 (2016): 817. doi:10.15537/smj.2016.7.15043
19. AlButaysh, Omar F et al. “Epidemiology of irritable bowel syndrome and its associated factors in Saudi undergraduate students.” Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association vol. 26,2 (2020): 89-93. doi:10.4103/sjg.SJG_459_19
20. Bin Abdulrahman, Khalid A et al. “Association of Migraine and Irritable Bowel Syndrome in Saudi Arabia: A Nationwide Survey.” BioMed research international vol. 2022 8690562. 18 Jan. 2022, doi:10.1155/2022/8690562
21. Ibrahim, Nahla Khamis Ragab et al. “Prevalence and predictors of irritable bowel syndrome among medical students and interns in King Abdulaziz University, Jeddah.” The Libyan journal of medicine vol. 8 21287. 19 Sep. 2013, doi:10.3402/ljm.v8i0.21287
22. Alaqeel, Meshal Khaled et al. “Prevalence of Irritable Bowel Syndrome and its Association with Anxiety among Medical Students at King Saud bin Abdulaziz University for Health Sciences in Riyadh.” Pakistan journal of medical sciences vol. 33,1 (2017): 33-36. doi:10.12669/pjms.331.12572
23. Bardisi, Bandar Mohammed et al. “Efficiency of diet change in irritable bowel syndrome.” Journal of family medicine and primary care vol. 7,5 (2018): 946-951. doi:10.4103/jfmpc.jfmpc_173_18
24. Ibrahim, Nahla Khamis et al. “Irritable bowel syndrome among nurses working in King Abdulaziz University Hospital, Jeddah, Saudi Arabia.” The Libyan journal of medicine vol. 11 30866. 30 Mar. 2016, doi:10.3402/ljm.v11.30866
25. Ahmed, S. A. S., Alotaibi, Y. M., Alayed, S. I., Al Alshaykh, O. M., Alothman, O. M., & Alhumaidi, A. A. Prevalence of irritable bowel syndrome among medical students in Imam Mohammad Ibn Saud Islamic University.‏
26. Alshammari, Omar Mohammad, et al. “Prevalence of irritable bowel syndrome among medical students in hail university, Saudi Arabia.” The Egyptian Journal of Hospital Medicine 71.2 (2018): 2581-2584.‏
27. Al.qarni, Ahlam, et al. “Prevalence of Irritable Bowel Syndrome among Nursing Students at King Abdulaziz University, Jeddah, Saudi Arabia.” American Journal of Nursing Research 7.5 (2019): 677-683.
28. SAAD ALSHAHRANI, M. D. “Prevalence and Risk Factors for Irritable Bowel Syndrome among Male Secondary School Saudi Students in Najran City, Saudi Arabia.” The Medical Journal of Cairo University 88.September (2020): 1917-1921.‏
29. Lee SY, Kim JH, Sung IK, Park HS, Jin CJ, Choe WH, et al. Irritable bowel syndrome is more common in women regardless of the menstrual phase: A Rome II-based survey. J Korean Med Sci. 2007;22:851.
30. Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:908–17.
31. Khoshkrood-Mansoori B, Pourhoseingholi MA, Safaee A, Moghimi-Dehkordi B, Sedigh-Tonekaboni B, Pourhoseingholi A, et al. Irritable bowel syndrome: A population-based study. J Gastrointestin Liver Dis. 2009;18:413–8.
32. Dong YY, Zuo XL, Li CQ, Yu YB, Zhao QJ, Li YQ. Prevalence of irritable bowel syndrome in Chinese college and university students assessed using Rome III criteria. World J Gastroenterol. 2010;16:4221–6
33. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther. 2003;17:643–50
34. Haas J, Phillips K, Sonneborn D, et al. Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual’s contry of residence. Med Care. 2004;42(7):707–714.
35. Quigley EM, Bytzer P, Jones R, Mearin F. Irritable bowel syndrome: the burden and unmet needs in Europe. Dig Liver Dis. 2006;38(10):717–723
36. Abdulmajeed A, Rabab MA, Sliem HA, Hebatallah NE. Pattern of irritable bowel syndrome and its impact on quality of life in primary health care center attendees, Suez governorate, Egypt. Pan Afr Med J. 2011;9:5.
37. Qin HY, Cheng CW, Tang XD, Bian ZX. Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol. 2014;20:14126–31.
38. Fass R, Fullerton S, Tung S, Mayer EA. Sleep disturbances in clinic patients with functional bowel disorders. Am J Gastroenterol. 2000;95:1195–2000.
39. Naeem SS, Siddiqui EU, Kazi AN, Memon AA, Khan ST, Ahmed B. Prevalence and factors associated with irritable bowel syndrome among medical students of Karachi, Pakistan: a cross-sectional study. BMC Res Notes. 2012;5:255.
40. Sugaya N, Nomura S. Relationship between cognitive appraisals of symptoms and negative mood for subtypes of irritable bowel syndrome. Biopsychosoc Med. 2008;2:9.
41. Alhazmi AH. Irritable bowel syndrome in secondary school male students in AlJouf Province, north of Saudi Arabia. J Pak Med Assoc. 2011;61:1111–5.
42. Saito YA, Petersen GM, Larson JJ, Atkinson EJ, Fridley BL, de Andrade M, et al. Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol. 2010;105:833–41.
43. Savas LS, White DL, Wieman M, Daci K, Fitzgerald S, Laday Smith S, et al. Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther. 2009;29:115–25.
44. Gros DF, Antony MM, McCabe RE, Swinson RP. Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression. J Anxiety Disord. 2009;23:290–6
45. Jones R, Latinovic R, Charlton J, Gulliford M. Physical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database. Aliment Pharmacol Ther. 2006;24:879–86.
46. Quigley EM, Bytzer P, Jones R, Mearin F. Irritable bowel syndrome: the burden and unmet needs in Europe. Dig Liver Dis. 2006;38(10):717–723
47. Kennedy TM, Jones RH, Hungin AP, O’flanagan H, Kelly P. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyperresponsiveness in the general population. Gut. 1998;43(6):770–774.
48. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J. 1978;2(6138):653–654.
49. Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol. 2012;107(7):991–1000.
50. Rasquin A, Di Lorenzo C, Forbes D, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006;130(5):1527–1537.
51. Maxwell PR, Mendall MA, Kumar D. Irritable bowel syndrome. Lancet. 1997;350(9092):1691–1695.
52. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38(9):1569–1580
53. Marmot M, Allen J, Bell R, Bloomer E, Goldblatt P, Consortium for the European Review of Social Determinants of Health and the Health Divide WHO European review of social determinants of health and the health divide. Lancet. 2012;380(9846):1011–1029.
54. Mendall MA, Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS) Eur J Gastroenterol Hepatol. 1998;10(1):59–62.
55. Grodzinsky E, Hallert C, Faresjö T, Bergfors E, Faresjö AO. Could gastrointestinal disorders differ in two close but divergent social environments? Int J Health Geogr. 2012;11:5.